Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Laxmi DentalNSE:LAXMIDENTL +0.99%28 ROE % is 16.57% as of Mar. 2026, which is 29% above its 10-year median of 12.83. GuruFocus rates NSE:LAXMIDENTL with a GF Score™ of 28/100. The stock has 4 warning signs investors should review. Among 800 Medical Devices & Instruments companies, Laxmi Dental ranks better than 81.87% on this metric.
ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Laxmi Dental's annualized net income for the quarter that ended in Mar. 2026 was ₹403 Mil. Laxmi Dental's average Total Stockholders Equity over the quarter that ended in Mar. 2026 was ₹2,433 Mil. Therefore, Laxmi Dental's annualized ROE % for the quarter that ended in Mar. 2026 was 16.57%.
The historical rank and industry rank for Laxmi Dental's ROE % or its related term are showing as below:
NSE:LAXMIDENTL'
s ROE % Range Over the Past 10 Years
Min: -87.18 Med: 12.83 Max: 82.24
Current: 12.76
During the past 5 years, Laxmi Dental's highest ROE % was 82.24%. The lowest was -87.18%. And the median was 12.83%.
NSE:LAXMIDENTL's ROE % is ranked better than 81.87% of 800
companies
in the Medical Devices & Instruments industry
Industry Median: 2.51
vs NSE:LAXMIDENTL: 12.76
Laxmi Dental (NSE:LAXMIDENTL) ROE % Explanation
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
Laxmi Dental ROE % Related Terms
Laxmi Dental ROE % Historical Data
* Premium members only.
The historical data trend for Laxmi Dental's ROE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:LAXMIDENTL vs ISRG, BDX, MDLN: ROE % Comparison
For the Medical Instruments & Supplies subindustry, Laxmi Dental's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Laxmi Dental ROE % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Laxmi Dental's ROE % distribution charts can be found below:
* The bar in red indicates where Laxmi Dental's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
ROE % is displayed in the 30-year financial page.
Laxmi Dental (NSE:LAXMIDENTL) has a ROE % of 16.57% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Laxmi Dental and its competitors. This is 29% above median its historical median of 12.83. According to the industry distribution chart, Laxmi Dental ranks #145 out of 800 companies in the Medical Devices & Instruments industry, placing it in the top 18.1%.
Is Laxmi Dental's ROE % too high?
Laxmi Dental's current ROE % of 16.57% is 29% above median its 10-year median of 12.83. The Medical Devices & Instruments industry median ROE % is 2.51. Laxmi Dental's value of 16.57% is 560.2% above this industry median. Based on the distribution chart, Laxmi Dental ranks #145 out of 800 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Laxmi Dental has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does Laxmi Dental's ROE % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Laxmi Dental ranks #145 out of 800 companies for ROE %. This places Laxmi Dental in the top 18% of its industry — outperforming the majority of peers. The industry median ROE % is 2.51. Laxmi Dental's value of 16.57% is 560.2% above this benchmark. While the company's 10-year median is 12.83 vs. the industry median of 2.51, Laxmi Dental has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Medical Devices & Instruments company?
The median ROE % among Medical Devices & Instruments companies is 2.51, based on 800 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Laxmi Dental's current ROE % of 16.57% is 560.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Laxmi Dental and its competitors. For the Medical Devices & Instruments industry, the median ROE % is 2.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Laxmi Dental's current ROE % is 16.57%, which is 29% above median its own 10-year median of 12.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Laxmi Dental stock overvalued right now?
Laxmi Dental (NSE:LAXMIDENTL) has a current ROE % of 16.57%. The current ROE % is 16.57%, which is 29% above median its 10-year median of 12.83 and 560.2% above the Medical Devices & Instruments industry median of 2.51. Laxmi Dental's overall GF Score™ is 28/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Laxmi Dental (NSE:LAXMIDENTL), the current ROE % is 16.57% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Laxmi Dental Ltd is an end-to-end integrated dental products company. Its products include custom-made crowns and bridges, branded dental products such as clear aligners, thermoforming sheets, and aligner-related products as a part of aligner solutions, and paediatric dental products. The Group has three reportable segments: Laboratory Business segment comprises dental prostheses, such as metal-free crowns & bridges, Porcelain Fused to Metal (PFM) Crowns and Bridges, and Dentures. The Aligners Business segment comprises dental aligners, Retainers, Raw Materials for Aligners, Sport Guards, Night Guards, and Sleep Apnea Devices. The Other Business segment comprises Dental distribution products used in Dental Laboratory, Dental Clinical Services, and Dental Educational Courses.
28GF Score
Get the complete analysis for NSE:LAXMIDENTL
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:LAXMIDENTL has been successfully added to your 
